Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: Accrufer | Mind Blowing Facts

Shield Therapeutics hails US market progress and mulls stateside listing

The Gateshead company said additional losses were to be expected as it carries out a plan to target US iron deficiency treatment demand

Birmingham Post · Apr 27, 2023

People on the move: key North East appointments and promotions

Companies featuring this week include Secure Trust Commercial Finance, Reproflex3 and Shield Therapeutics

Birmingham Post · Apr 7, 2023

Shield Therapeutics revenues boosted by US sales of iron deficiency pills

The pharmaceuticals firm recently joined forced with Pennsylvania-based Viatris to tackle the American market

Birmingham Post · Feb 9, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

Shield Therapeutics secures £15.1m in raise and seals deal with healthcare company

The iron deficiency drug specialist will use the proceeds to mount a campaign on the US market

Birmingham Post · Dec 13, 2022

Gateshead's Shield Therapeutics says US expansion will be aided by new shelf life ruling

The company launched its lead drug Accrufer in the US last year

Birmingham Post · Oct 27, 2022

Losses widen at Shield Therapeutics though sales and prescriptions of its drugs grow

The maker of iron deficiency tablets says there is a huge unmet need for its products in the US were about 20 million people suffer anaemia

Birmingham Post · Sep 8, 2022

Shield Therapeutics finalises $10m loan agreement from cornerstone shareholder

'Shield is fortunate to be able to count on continued support by an established pharmaceutical company like AOP'

Birmingham Post · Aug 1, 2022

Read news from The Economist, FT, and more,
with one subscription

Pharma firm Shield Therapeutics seals $10m shareholder loan after strong start to 2022

The Gateshead firm also saw a 'transformational' 2021 with licensing activities in the US driving up prescriptions

Birmingham Post · Jun 30, 2022

Coverage From

Birmingham Post

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.